Pr. Talbot et al., A CLINICAL ROLE FOR TC-99M-HMPAO SPECT IN THE INVESTIGATION OF DEMENTIA, Journal of Neurology, Neurosurgery and Psychiatry, 64(3), 1998, pp. 306-313
Objectives-To provide the clinician with a guide to the clinical utili
ty of Tc-99m-HMPAO single photon emission computed tomography (SPECT)
and to the interpretation of specific test results in the differential
diagnosis of dementia. Methods-Three hundred and sixty three patients
with dementia were studied prospectively for a median three (range 1-
6) years and classified into disease groups on the basis of establishe
d clinical criteria. The degree to which different patterns of cerebra
l blood flow (CBF) abnormality found on Tc-99m-HMPAO SPECT imaging at
the time of initial patient presentation modified clinical diagnoses w
as determined by calculating the Likelihood ratios for pairwise diseas
e group comparisons. The optimal clinical usage of Tc-99m-HMPAO SPECT
was determined by calculating the percentage of significant test resul
ts for each pairwise disease group comparison. Results-Bilateral poste
rior CBF abnormality was found to significantly increase the odds of a
patient having Alzheimer's disease as opposed to vascular dementia or
frontotemporal dementia. Bilateral anterior CBF abnormality significa
ntly increased the odds of a patient having frontotemporal dementia as
opposed to Alzheimer's disease, vascular dementia, or Lewy body disea
se. ''Patchy'' CBF changes significantly increased the odds of a patie
nt having vascular dementia as opposed to Alzheimer's disease. Unilate
ral anterior, unilateral anterior plus unilateral posterior, and gener
alised CBF abnormality failed to contribute to the differentiation of
any of these forms of dementia. Conclusions-Tc-99m-HMPAO SPECT was fou
nd to be most useful in distinguishing Alzheimer's disease from vascul
ar dementia and fronto temporal dementia, and least useful in differen
tiating between Alzheimer's disease and Lewy body disease, and between
vascular dementia, frontotemporal dementia, and progressive aphasia.
It is suggested that CBF SPECT should be used selectively and as an ad
junct to clinical evaluation and CT.